The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


The Medicines Company DK ApSEU/1/20/1494/001

Main Information

Trade NameLyptimzia
Active SubstancesInclisiran
Dosage FormSolution for injection in pre-filled syringe
Licence HolderThe Medicines Company DK ApS
Licence NumberEU/1/20/1494/001

Group Information

ATC CodeC10AX Other lipid modifying agents
C10AX16 inclisiran


License statusAuthorised
Licence Issued09/12/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back